中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors

文献类型:期刊论文

作者Liu, Meiying6,7; Zhou, Guizhen7,8; Su, Wenhong3,6; Gu, Yuejiao5,6; Gao, Mingshan6; Wang, Kun7; Huo, Ruifeng8; Li, Yupeng1,2; Zhou, Zehui6; Chen, Kaixian5,7,8
刊名ACS MEDICINAL CHEMISTRY LETTERS
出版日期2023-01-12
页码183-190
关键词KRAS mutation SOS1-KRAS interaction SOS1 inhibitor combination therapy
DOI10.1021/acsmedchemlett.2c00490
文献子类Article
英文摘要The use of small molecular modulators to target the guanine nucleotide exchange factor SOS1 has been demonstrated to be a promising strategy for the treatment of various KRAS-driven cancers. In the present study, we designed and synthesized a series of new SOS1 inhibitors with the pyrido[2,3-d]pyrimidin-7one scaffold. One representative compound 8u showed comparable activities to the reported SOS1 inhibitor BI-3406 in both the biochemical assay and the 3-D cell growth inhibition assay. Compound 8u obtained good cellular activities against a panel of KRAS G12-mutated cancer cell lines and inhibited downstream ERK and AKT activation in MIA PaCa-2 and AsPC-1 cells. In addition, it displayed synergistic antiproliferative effects when used in combination with KRAS G12C or G12D inhibitors. Further modifications of the new compounds may give us a promising SOS1 inhibitor with favorable druglike properties for use in the treatment of KRAS-mutated patients.
WOS关键词DISCOVERY ; CANCER
WOS研究方向Pharmacology & Pharmacy
语种英语
WOS记录号WOS:000934292900001
出版者AMER CHEMICAL SOC
源URL[http://119.78.100.183/handle/2S10ELR8/309719]  
专题新药研究国家重点实验室
通讯作者Zhang, Sulin; Xu, Tianfeng
作者单位1.Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA
2.Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA;
3.Univ Sci & Technol China, Nano Sci & Technol Inst, Suzhou 215123, Peoples R China;
4.Univ Chinese Acad Sci, Hangzhou Inst Adv Study, Sch Pharmaceut Sci & Technol, Hangzhou 310024, Peoples R China;
5.Univ Chinese Acad Sci, Beijing 100049, Peoples R China;
6.Chinese Acad Sci, Shanghai Inst Mat Med, Dept Med Chem, Shanghai 201203, Peoples R China;
7.Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China;
8.Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr, State Key Lab Drug Res, Shanghai 201203, Peoples R China;
推荐引用方式
GB/T 7714
Liu, Meiying,Zhou, Guizhen,Su, Wenhong,et al. Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors[J]. ACS MEDICINAL CHEMISTRY LETTERS,2023:183-190.
APA Liu, Meiying.,Zhou, Guizhen.,Su, Wenhong.,Gu, Yuejiao.,Gao, Mingshan.,...&Xu, Tianfeng.(2023).Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors.ACS MEDICINAL CHEMISTRY LETTERS,183-190.
MLA Liu, Meiying,et al."Design, Synthesis, and Bioevaluation of Pyrido[2,3-d]pyrimidin-7-ones as Potent SOS1 Inhibitors".ACS MEDICINAL CHEMISTRY LETTERS (2023):183-190.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。